Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Prepaid Assets (2016 - 2025)

Outlook Therapeutics (OTLK) has disclosed Prepaid Assets for 8 consecutive years, with $4.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 28.28% to $4.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.9 million, a 28.28% decrease, with the full-year FY2025 number at $4.5 million, changed N/A from a year prior.
  • Prepaid Assets was $4.9 million for Q4 2025 at Outlook Therapeutics, up from $4.5 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $6.9 million in Q4 2024 to a low of $4.5 million in Q3 2025.